• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前淋巴细胞与单核细胞比值及血小板与淋巴细胞比值作为非小细胞肺癌患者的预后预测指标

Preoperative lymphocyte-to-monocyte ratio versus platelet-to-lymphocyte ratio as a prognostic predictor for non-small cell lung cancer patients.

作者信息

Yan Haixi, Cai Linling, Chen Shuaishuai, Li Jun

机构信息

Taizhou Enze Medical Center(Group), Taizhou Hospital of Zhejiang Province, Department of Clinical Laboratory, Linhai, Zhejiang Province, China.

出版信息

J Med Biochem. 2020 Jan 23;39(2):160-164. doi: 10.2478/jomb-2019-0031.

DOI:10.2478/jomb-2019-0031
PMID:33033447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7526025/
Abstract

BACKGROUND

We investigated the prognostic value of the preoperative lymphocyte-to-mononuclear ratio (LMR) and platelet-to-lymphocyte ratio (PLR) in a large cohort of patients with non-small cell lung cancer (NSCLC).

METHODS

Clinical-pathological data from 507 NSCLC patients at Taizhou Hospital of Zhejiang Province between 2010 and 2016 were retrospectively evaluated. X-tile software was used to assess the optimal cutoff levels for LMR and PLR. Univariate and multivariate Cox regression models were used to assess the prognostic factors.

RESULTS

The median follow-up duration after surgical resection was 34.5 months. Patients were stratified into 2 groups by LMR (2.6 and > 2.6) and PLR (179.6 and > 179.6). Our results revealed that lower LMR (HR = 3.163 (1.821-5.493), P = 0.000), age (HR = 2.252 (1.412-3.592), P = 0.001), T stage (HR = 3.749 (2.275-6.179), P = 0.000), N stage (HR = 3.106 (1.967-4.902), P = 0.000), and cut edge (HR = 3.830 (1.077-13.618), P = 0.038) were considered to be independent indicators for overall survival (OS) of NSCLC patients. For disease-free survival (DFS), age, sex, T stage, N stage, LMR and cut edge were verified to be independent prognostic factors in patients with NSCLC.

CONCLUSIONS

In the study cohort, reduced LMR was a robust independent predictor for both OS and DFS in patients with NSCLC who underwent surgical resection.

摘要

背景

我们在一大群非小细胞肺癌(NSCLC)患者中研究了术前淋巴细胞与单核细胞比值(LMR)和血小板与淋巴细胞比值(PLR)的预后价值。

方法

回顾性评估了2010年至2016年期间浙江省台州医院507例NSCLC患者的临床病理数据。使用X-tile软件评估LMR和PLR的最佳截断水平。采用单因素和多因素Cox回归模型评估预后因素。

结果

手术切除后的中位随访时间为34.5个月。患者按LMR(2.6及>2.6)和PLR(179.6及>179.6)分为两组。我们的结果显示,较低的LMR(HR = 3.163(1.821 - 5.493),P = 0.000)、年龄(HR = 2.252(1.412 - 3.592),P = 0.001)、T分期(HR = 3.749(2.275 - 6.179),P = 0.000)、N分期(HR = 3.106(1.967 - 4.902),P = 0.000)和切缘(HR = 3.830(1.077 - 13.618),P = 0.038)被认为是非小细胞肺癌患者总生存期(OS)的独立指标因素。对于无病生存期(DFS),年龄、性别、T分期、N分期、LMR和切缘被证实是非小细胞肺癌患者的独立预后因素。

结论

在该研究队列中,LMR降低是接受手术切除的非小细胞肺癌患者OS和DFS的有力独立预测指标。

相似文献

1
Preoperative lymphocyte-to-monocyte ratio versus platelet-to-lymphocyte ratio as a prognostic predictor for non-small cell lung cancer patients.术前淋巴细胞与单核细胞比值及血小板与淋巴细胞比值作为非小细胞肺癌患者的预后预测指标
J Med Biochem. 2020 Jan 23;39(2):160-164. doi: 10.2478/jomb-2019-0031.
2
Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.术前血小板与淋巴细胞比值和淋巴细胞与单核细胞比值联合对ⅠB期非小细胞肺癌手术患者的预后意义
Cancer Manag Res. 2018 Nov 8;10:5411-5422. doi: 10.2147/CMAR.S177320. eCollection 2018.
3
Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.联合 FDG-PET 摄取的 SUVmax 和淋巴细胞-单核细胞比值在接受化疗的 IIIB-IV 期非小细胞肺癌患者中的预后价值。
BMC Cancer. 2021 Jan 14;21(1):66. doi: 10.1186/s12885-021-07784-x.
4
Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience.全身炎症生物标志物预测接受立体定向消融放疗的早期非小细胞肺癌患者的生存情况——单中心经验
J Cancer. 2018 Jan 1;9(1):182-188. doi: 10.7150/jca.21703. eCollection 2018.
5
Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.可切除食管鳞状细胞癌患者术前淋巴细胞与单核细胞比值的预后意义
Asian Pac J Cancer Prev. 2015;16(6):2245-50. doi: 10.7314/apjcp.2015.16.6.2245.
6
[Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].[术前外周血淋巴细胞与单核细胞比值对Ⅲ期结肠癌患者预后的评估价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):73-78.
7
The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer.术后中性粒细胞与淋巴细胞比值及其变化可预测Ⅰ期非小细胞肺癌完全切除术后的生存情况。
Onco Targets Ther. 2016 Oct 21;9:6529-6537. doi: 10.2147/OTT.S117290. eCollection 2016.
8
Predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and lymphocyte-to-monocyte ratio (LMR) in patients with non-small cell lung cancer after radical lung cancer surgery.血红蛋白、白蛋白、淋巴细胞及血小板(HALP)评分和淋巴细胞与单核细胞比值(LMR)对非小细胞肺癌患者根治性肺癌手术后的预测价值。
Ann Transl Med. 2021 Jun;9(12):976. doi: 10.21037/atm-21-2120.
9
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).IV期非小细胞肺癌(NSCLC)的预后生物标志物:中性粒细胞与淋巴细胞比值(NLR)、淋巴细胞与单核细胞比值(LMR)、血小板与淋巴细胞比值(PLR)以及晚期肺癌炎症指数(ALI)。
Transl Lung Cancer Res. 2019 Dec;8(6):886-894. doi: 10.21037/tlcr.2019.11.16.
10
Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.血小板计数与淋巴细胞/单核细胞比值联合对伴有恶性胸腔积液的 IV 期非小细胞肺癌的预后价值。
PLoS One. 2018 Jul 13;13(7):e0200341. doi: 10.1371/journal.pone.0200341. eCollection 2018.

引用本文的文献

1
Risk factor analysis and nomogram prediction model construction of postoperative complications of thoracoscopic non-small cell lung cancer.胸腔镜非小细胞肺癌术后并发症的危险因素分析及列线图预测模型构建
J Thorac Dis. 2024 Jun 30;16(6):3655-3667. doi: 10.21037/jtd-24-113. Epub 2024 Jun 12.
2
Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer.那不勒斯预后评分对不可切除的 III 期非小细胞肺癌患者的预测价值评估
J Inflamm Res. 2021 Nov 23;14:6129-6141. doi: 10.2147/JIR.S341399. eCollection 2021.

本文引用的文献

1
Soluble sPD-L1 and Serum Amyloid A1 as Potential Biomarkers for Lung Cancer.可溶性sPD-L1和血清淀粉样蛋白A1作为肺癌的潜在生物标志物
J Med Biochem. 2019 May 11;38(3):332-341. doi: 10.2478/jomb-2018-0036. eCollection 2019 Jul.
2
Association of Overexpressed Gene with Altered and Genes Contributes to Non-small Cell Lung Carcinoma Pathogenesis.过表达基因与改变的基因的关联促成非小细胞肺癌发病机制。
J Med Biochem. 2019 Mar 3;38(2):188-195. doi: 10.2478/jomb-2018-0022. eCollection 2019 Apr.
3
Preoperative lymphocyte-to-monocyte ratio predicts breast cancer outcome: A meta-analysis.术前淋巴细胞与单核细胞比值预测乳腺癌结局:一项荟萃分析。
Clin Chim Acta. 2018 Sep;484:1-6. doi: 10.1016/j.cca.2018.05.031. Epub 2018 May 29.
4
Prognostic and diagnostic impact of fibrinogen, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome.纤维蛋白原、中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对胸腺上皮肿瘤预后的预后和诊断影响
Oncotarget. 2018 Apr 24;9(31):21861-21875. doi: 10.18632/oncotarget.25076.
5
Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer.纤维蛋白原浓度与中性粒细胞与淋巴细胞比值联合检测对可切除非小细胞肺癌患者的预后意义
Cancer Biol Med. 2018 Feb;15(1):88-96. doi: 10.20892/j.issn.2095-3941.2017.0124.
6
Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis.血小板与淋巴细胞比值在胆道癌中的应用:综述与荟萃分析。
Clin Chim Acta. 2017 Nov;474:102-107. doi: 10.1016/j.cca.2017.09.006. Epub 2017 Sep 10.
7
Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival.与中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值相比,术前淋巴细胞与单核细胞比值是预测单纯性结直肠癌肝转移患者生存率的更优指标。
Onco Targets Ther. 2017 Jul 27;10:3789-3799. doi: 10.2147/OTT.S140872. eCollection 2017.
8
The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis.血小板与淋巴细胞比值作为卵巢癌患者预后的预测指标:一项荟萃分析。
Climacteric. 2017 Oct;20(5):448-455. doi: 10.1080/13697137.2017.1326894. Epub 2017 Jun 1.
9
Gut Microbiota, Inflammation, and Colorectal Cancer.肠道微生物群、炎症与结直肠癌
Annu Rev Microbiol. 2016 Sep 8;70:395-411. doi: 10.1146/annurev-micro-102215-095513.
10
Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma.炎症细胞因子调控肝癌细胞的转分化和去分化。
Gastroenterology. 2016 Oct;151(4):607-15. doi: 10.1053/j.gastro.2016.06.052. Epub 2016 Jul 19.